EXO FACE® Perfection Moisturizer
EXO FACE® Perfection Moisturizer is used in prescriber-directed longevity, peptide, antioxidant, or skin-longevity protocols. Published evidence varies substantially by ingredient, so the page avoids unsupported disease-treatment claims.
EXO FACE® Perfection Moisturizer is a compounded topical facial moisturizer formulated for prescriber-directed daily use. It combines an extracellular vesicle (exosome) complex within a balanced moisturizing vehicle designed to deliver regenerative biological signals while simultaneously supporting the skin barrier through humectant, emollient, and occlusive components. The preparation addresses daily skin aging maintenance, hydration deficit, and regenerative cellular support concurrently. Genesis Compounding prepares this as a prescription-only, patient-specific 503A compounded preparation; it is not FDA-approved as a compounded product.
| Active Ingredient | Pharmacologic Role |
|---|---|
| Exosome/Extracellular Vesicle Complex (EXO FACE proprietary blend) | Cell-derived or plant-derived extracellular vesicles delivering growth factors, anti-inflammatory miRNAs, and regenerative signaling proteins to facial fibroblasts and keratinocytes within the context of a daily moisturizing vehicle, providing ongoing low-level regenerative support alongside barrier hydration. |
Route: Topical facial application.
Apply a small amount (pea-sized quantity for the full face) to freshly cleansed skin. Gently massage in upward, outward motions until fully absorbed. Can be used as a final moisturizing step in a morning or evening skincare routine, over serums but before sunscreen (if used in the morning). Avoid contact with eyes and mucosal surfaces. May be applied to the neck and décolletage as directed by the prescriber.
Application frequency is determined by the prescribing clinician. Standard moisturizer use:
- Apply once or twice daily (morning and/or evening) to the face and neck as directed.
- This preparation is designed for ongoing daily maintenance; consistent use over months supports sustained regenerative benefit.
- Clinical response assessment recommended at 8–12 weeks.
As a daily-use moisturizer with embedded exosome technology, EXO FACE provides dual mechanisms of action:
- Barrier support: The moisturizing vehicle (humectants, emollients, occlusives) restores and maintains the skin's lipid barrier, reducing TEWL, preventing moisture loss, and supporting the physical barrier against environmental insults — all of which worsen inflammatory aging (inflammaging).
- Exosome regenerative signaling: With each application, vesicle-delivered growth factors (EGF, TGF-β, VEGF) and miRNAs activate fibroblast collagen synthesis pathways, suppress NF-κB-driven SASP signaling in senescent cells, and promote keratinocyte turnover — cumulatively improving skin density, elasticity, and texture over time at lower intensity than a concentrated treatment serum.
Clinical Context: EXO FACE Perfection Moisturizer is intended for prescriber-directed daily maintenance in patients enrolled in anti-aging skin care protocols, post-procedure recovery programs, or as a base layer in more intensive skin longevity regimens. The daily-use moisturizer format delivers regenerative support at lower per-session intensity but with high cumulative exposure through daily application, supporting sustained collagen maintenance and barrier integrity.
Monitoring Considerations:
- Assess skin hydration, barrier integrity (TEWL), and visible aging markers at 3-month intervals.
- In patients with acne-prone skin, review the formulation's comedogenicity profile with the prescriber before regular use, as occlusive vehicles may affect acne-prone skin differently.
Contraindications:
- Known hypersensitivity to any component of the moisturizer.
- Active facial infection or significant inflammatory dermatosis in the application area.
Warnings & Precautions:
- For topical facial use only. Avoid ocular contact.
- Monitor acne-prone patients for comedone formation with regular occlusive moisturizer use.
Drug Interactions:
- No established pharmacokinetic drug interactions at topical application. Avoid simultaneous application with concentrated vitamin C preparations if the formulation contains copper peptide components, to prevent oxidative deactivation.
Common Side Effects: Well tolerated. Potential for mild perioral or periorbital irritation if applied near those areas. Rare contact allergy to excipients.
Store at controlled room temperature (20–25°C / 68–77°F). Protect from light and heat. If refrigeration is required, see the prescription label. Keep out of reach of children. Use before the BUD assigned by Genesis Compounding.
Can I use this as my primary daily moisturizer?
Yes — EXO FACE is designed for daily use as a moisturizing foundation step in your skincare routine. It provides both hydration support and low-level ongoing exosome regenerative signaling with each daily application.
Should I use this before or after serums?
Apply serums (thinner consistency) first, then EXO FACE moisturizer as a final skin-sealing step. If using in the morning, follow with sunscreen as the last step.
Is this FDA-approved?
No. This is a prescription-only 503A compounded preparation made by Genesis Compounding per your prescriber's specifications. It is not an FDA-approved drug product.
Can I use this if I have acne-prone skin?
Discuss the vehicle composition with your prescriber. Occlusive moisturizers can potentially contribute to comedone formation in acne-prone patients, and your prescriber can advise whether this formulation is appropriate for your skin type.
How long do I need to use this before seeing results?
Daily moisturizing benefits (hydration, reduced tightness) are immediate. Cumulative regenerative improvements from the exosome component become apparent over 8–12 weeks of consistent use, and continue to develop with ongoing daily application.
Clinical References
Authoritative sources reviewed in preparing this clinical summary. Provided for prescriber reference; not a substitute for the prescriber’s clinical judgment.